Astragaloside III
Cat. No.：YN482454
| 产品名称: | Astragaloside III |
| CAS No.: | 84687-42-3 |
| Chemical Name: | (3β,6α,16β,20R,24S)-20,24-epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl 2-O-β-D-glucopyranosyl-β-D-xylopyranoside |
| Synonyms: | |
| 分子量: | 784.97 |
| 分子式: | C₄₁H₆₈O₁₄ |
| SMILES: | O[C@@H]1[C@@H](O)[C@]([H])(O[C@@H]2[C@@H](O)[C@H](O)CO[C@]2(O[C@@H]3C(C)(C)[C@@]([C@@H](O)C[C@]4([H])[C@@]56CC[C@@]7(C)[C@@]4(C)C[C@H](O)[C@@]7([C@]8(C)O[C@H](C(C)(O)C)CC8)[H])([H])[C@]5(C6)CC3)[H])O[C@H](CO)[C@H]1O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | 黄芪皂苷III (Astragaloside III)是从黄芪中分离到的一种天然产物。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Ren, S., Zhang, H., Mu, Y., et al.Pharmacological effects of Astragaloside IV: A literature reviewJ. Tradit. Chin. Med.33(3),413-416(2013)
Liu, X.-H., Guo, L., Yang, Y.-L., et al.Development and validation of a rapid and simple UPLC-ESI-MS method for pharmacokinetics and tissue distribution of astragaloside III in ratsJ. Chromatogr. Sci.54(5),811-818(2016)
Zhai, Y., Li, P., Wang, M., et al.Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic studyBiomed. Chromatogr.30(2),105-110(2016)
